ÓÐÕâÑùһȺÈË£¬´Ó³öÉúÆð¾ÍÎÞ·¨ÏñÕý³£º¢×ÓÒ»ÑùËÁÒâ±¼³ÛÍæË££¬²»¾Òâ¼äµÄС¿ÄÅö¶¼¿ÉÄÜÈÃËûÃÇѪÁ÷²»Ö¹£¬»»¿ÅÑÀ³ÝÒ²¿ÉÄÜΣ¼°ÉúÃü......ËûÃÇÊDz£Á§Ò»Ñùƽ³£¡°Ò×Ë顱µÄº¢×Ó£¬ÐèÒª¸ü¶àµÄÌåÌùºÍºÇ»¤£¬ËûÃǾÍÊÇѪÓѲ¡»¼Õß¡£
ÿÄêµÄ4ÔÂ17ÈÕÊÇÌìÏÂѪÓѲ¡ÈÕ¡£ÈÃÎÒÃÇÒ»ÆðÏàʶѪÓѲ¡£¬¹ØעѪÓѲ¡µÄ¿Æѧ·ÀÖΡ£
ʲôÊÇѪÓѲ¡£¿
ѪÓѲ¡ÊÇÒ»×éÒÅ´«ÐÔ³öѪÐÔ¼²²¡£¬ÆäÌØÕ÷ÔÚÓÚ»¼ÕßÌåÄÚȱ·¦Ä³Ð©Òªº¦µÄÄýѪÒò×Ó£¬µ¼ÖÂѪҺÎÞ·¨Õý³£Äý¹Ì£¬´Ó¶øÒý·¢Ò»ÏµÁгöѪ֢״¡£
ƾ֤Ëùȱ·¦µÄÄýѪÒò×ÓÖÖÀ࣬ѪÓѲ¡Ö÷Òª·ÖΪÒÔÏÂÁ½ÖÖÀàÐÍ£º
ѪÓѲ¡A£¨¾µä·¶ÑªÓѲ¡£©£ºÕâÊÇ×î³£¼ûµÄÀàÐÍ£¬Õ¼ËùÓÐѪÓѲ¡²¡ÀýµÄÔ¼80%-85%¡£ËüÊÇÓÉÄýѪÒò×Ó VIII£¨Òò×Ó°Ë£©µÄȱ·¦»ò¹¦Ð§ÕÏ°ÒýÆðµÄ¡£
ѪÓѲ¡B£¨ÒÒÐÍѪÓѲ¡£©£ºÕâÀàѪÓѲ¡Õ¼Ê£ÓಡÀýµÄÔ¼15%-20%£¬ÓÉÄýѪÒò×Ó IX£¨Òò×Ӿţ©µÄȱ·¦»ò¹¦Ð§ÕÏ°ÒýÆðµÄ¡£
ѪÓѲ¡»¼Õß×î´óµÄÌصã¾ÍÊÇ´ÓС¾Í±£´æ³öѪÇãÏò£¬ÔÚÊÜÉË»ò½ÓÊÜÊÖÊõºó£¬ÇáÕßÌ«¹ýÓÙѪ£¬ÖØÕßѪÁ÷²»Ö¹£»±ðµÄ£¬ÑªÓѲ¡»¼Õß³£ÓпڱdzöѪºÍ賦µÀ³öѪµÄÖ¢×´£¬»¹¿ÉÄÜÓÉÓÚÖظ´µÄÊàŦ³öѪ¶øÌÛÍ´ÄÑÈÌÉõÖÁÊàŦËðÉË¡¢»ûÐζøµ¼Ö²м²¡£
ѪÓѲ¡ÎÞ·¨¸ùÖΣ¬ÐèÖÕÉúÕÕ»¤
Òź¶µÄÊÇ£¬ÁÙ´²ÉÏÖÁ½ñÉÐÎÞ³¹µ×ÖÎÓúѪÓѲ¡µÄÒªÁ죬»¼Õß±£´æÖÕÉíÕÕ»¤µÄÐèÇó¡£È«Çòҽѧ½çÒ»Á¬ÖÂÁ¦ÓÚ¸ÄÉÆѪÓѲ¡µÄÖÎÁÆÊÖ¶ÎÓëÌáÉý»¼ÕßµÄÉúÑÄÖÊÁ¿£¬µ«Ïֽ׶εĽ¹µãÕ½ÂÔÈÔ¼¯ÖÐÔÚ¶àѧ¿ÆÐ×÷µÄ×ÛºÏÕÕ»¤ÉÏ¡£
ѪÓѲ¡»¼ÕßµÄÖÎÁƺÍÕÕ»¤ÓÐÒÔÏÂÒªº¦Òªµã£º
Ìæ»»Òò×ÓÖÎÁÆ
ÕâÊÇѪÓѲ¡ÏÖÔÚµÄÖ÷ÒªÖÎÁÆÒªÁ죬°üÀ¨Êä×¢ÏìÓ¦µÄÄýѪÒò×ÓÀ´Ôö²¹»¼ÕßµÄÄýѪ¹¦Ð§£¬ÒÔïÔÌ»ò×èÖ¹³öѪÊÂÎñµÄ±¬·¢¡£
³öѪÊÂÎñ¹ÜÀí
µ±³öѪÊÂÎñ±¬·¢Ê±£¬ÊµÊ±½ÓÄɲ½·¥ÒÔֹѪºÍ¼õÇáÖ¢×´ÖÁ¹ØÖ÷Òª£¬°üÀ¨Ê¹Óñù·ó¡¢Õ¥È¡¡¢Ìá¸ß»¼Ö«¡¢Êä×¢ÄýѪÒò×ÓµÈÒªÁì¡£
ÉúÑÄ·½·¨¹ÜÀí
¾ÙÐÐÊʶȵ͹¥»÷Ô˶¯£¬¼á³ÖƽºâÒûʳ£¬×èÖ¹¸ßΣº¦»î¶¯ºÍʹÓÿÉÄÜ×ÌÈÅÄýѪµÄÒ©Îï¡£
°´ÆÚ¼à²âÓëµ÷½âÖÎÁÆ
°´ÆÚ¼ì²âÄýѪ¹¦Ð§¡¢ÆÀ¹ÀÊàŦ¿µ½¡¡¢É¸²é²¢·¢Ö¢£¬Æ¾Ö¤²¡Çéµ÷½âÌæ»»Òò×ÓÖÎÁƼƻ®¡£
ÒÅ´«×Éѯ
»¼Õß¼°Æä¼ÒÍ¥Ó¦½ÓÊÜÒÅ´«×Éѯ£¬Ã÷È·²¡Òò¡¢ÒÅ´«·½·¨£¬»ñÈ¡ÉúÓýΣº¦¹ÜÀí½¨Òé¡£
30%ÒÔÉϵÄѪÓѲ¡»¼Õß²¢Ã»ÓмÒ×åÊ·
ËäÈ»£¬ÑªÓѲ¡ÊÇÒ»ÖÖÒÅ´«ÐÔ¼²²¡£¬µ«²¢²»ÁÏζ×ÅÕý³£¿µ½¡µÄØøÙ³¾Í²»»áÉú³ö»¼ÓÐѪÓѲ¡µÄº¢×Ó¡£ÊÂʵÉÏ£¬Í³¼ÆÊý¾ÝÕ¹ÏÖ£¬Áè¼Ý30%µÄѪÓѲ¡»¼Õß²¢ÎÞÒÑÖªµÄ¼Ò×岡ʷ¡£ÕâÊÇΪʲôÄØ£¿Ö÷ÒªÓÐÈýÖÖ¿ÉÄܵÄÔµ¹ÊÔÓÉ£º
ÒþÐÔÒÅ´«ÌØÕ÷£ºÑªÓѲ¡×ñÕÕXȾɫÌåÁ¬ËøÒþÐÔÒÅ´«Ä£Ê½¡£Å®ÐÔЯ´øÕßͨ³£½öÓÐÒ»¸öÖ²¡»ùÒò£¬×ÔÉí²»·¢²¡£¬µ«ÔÚÉúÓýÀú³ÌÖÐÓпÉÄܽ«¸Ã»ùÒòת´ï¸ø×ÓÅ®¡£Òò´Ë£¬¼Ò×åÖпÉÄܱ£´æδ±»Ê¶±ðµÄЯ´øÕߣ¬Ö±ÖÁÆä×ÓÅ®·ºÆðÖ¢×´²ÅÏÔ¶³öÒÅ´«Á´¡£
¼Ò×åÊ·¼Í¼¾ÖÏÞ£ºÓÐʱ£¬¼Ò×岡ʷ¼Í¼¿ÉÄܲ»È«»ò½û¾øÈ·¡£ÊÜÏÞÓÚÊìϤȱ·¦»ò¹ýÍùÒ½ÁÆˮƽÊÖÏÞÐÔ£¬¼Ò×åÖпÉÄÜÒÑÓл¼²¡Õ߶øδ±»Ã÷È·Õï¶Ï£¬´Ó¶øÔÚÍâòÉÏ·ºÆðÎÞ¼Ò×åÊ·µÄÕ÷Ïó¡£
з¢Í»±ä£ºÖ»¹ÜÏà¶Ô½ÏÉÙ¼û£¬µ«ÑªÓѲ¡²¡ÀýÒ²¿ÉÄÜÓÉз¢Í»±äÒýÆð¡£¼´ÔÚâïÊÑË«·½µÄÉúֳϸ°ûÐγɻòÊܾ«ÂÑÐγɡ¢ÅßÌ¥·¢ÓýÔçÆÚ±¬·¢µÄ»ùÒòÍ»±ä£¬×ª´ïµ½ÁËÏÂÒ»´ú¡£ÕâÖÖÇéÐÎÔÚÒÅ´«Æ×ϵÉÏÌåÏÖΪ¡°Í»È»·ºÆ𡱣¬Ã»ÓÐÏÈÇ°µÄ¼Ò×廼²¡¼Í¼¡£
Òò´Ë£¬×ÝÈ»¼Ò×åÖÐδÔø·ºÆð¹ýѪÓѲ¡²¡Àý£¬¸öÌåÈÔÓпÉÄÜî¾»¼¸Ã²¡¡£¹ØÓÚÈκβ»Ã÷Ôµ¹ÊÔÓɵÄÒ»Á¬ÐÔ»òÖظ´·ºÆðµÄ³öѪ֢״£¬ÈçƤ·ôÓÙѪ¡¢ÆµÈÔÁ÷±ÇѪ¡¢¿ÚÇ»³öѪ£¬ÒÔ¼°ÊàŦÖ×ÕÍÌÛÍ´µÈ£¬¾ùÓ¦Ìá¸ßСÐÄ£¬ÊµÊ±¾ÍÒ½¡£
»ùÒòɸ²éÖúÁ¦ÑªÓѲ¡·À¿ØÌáÉýÉú³Ý¿µ½¡ËØÖÊ
»ùÒòɸ²éÔÚѪÓѲ¡µÄ·À¿ØÖоßÓв»¿ÉÌæ»»µÄְλ¡£Ëü²»µ«ÄÜÓÐÓÃÔ¤·ÀѪÓѲ¡»¼¶ùµÄ³öÉú£¬ÖúÁ¦ÔçÆÚÕï¶ÏÓë¸ÉÔ¤£¬»¹ÄÜÕ¹ÏÖÒþÐÔЯ´øÕßµÄÒÅ´«Î£º¦£¬Ö¸µ¼ÖÖÖÖÈËȺ¾ÙÐкÏÀíµÄÉúÓý¹ÜÀí£¬¶ÔÌáÉýÉú³Ý¿µ½¡ËØÖÊ¡¢¼õÇáÉç»áÒ½ÁƼ縺Æðµ½ÁËÒªº¦×÷Óá£
¹ØÓÚѪÓѲ¡»¼ÕßÀ´Ëµ£¬ÈôÊÇÉúÓýÁËͬÑù»¼ÓÐѪÓѲ¡µÄº¢×Ó£¬½«¶Ô¼ÒÍ¥´øÀ´¸ü¼«Öصļ縺¡£Òò´Ë£¬ÑªÓѲ¡»¼ÕߵļÒÍ¥ÐèÒª¾ÙÐÐרҵµÄÒÅ´«×ÉѯºÍÐëÒªµÄ»ùÒò¼ì²â£¬ÔÚרҵҽÉúµÄÖ¸µ¼ÏÂÑ¡Ôñ²úÇ°Õï¶Ï»òµÚÈý´ú¸¨ÖúÉúÖ³µÈÊֶΣ¬×èÖ¹ÏÂÒ»´ú»¼¶ùµÄ³öÉú¡£
±ðµÄ£¬Ã»ÓÐÁÙ´²ÌåÏֵĿµ½¡Å®ÐÔÒ²¿ÉÄÜÊÇѪÓѲ¡Ö²¡»ùÒòµÄЯ´øÕߣ¬¶øËýÃǵÄ×ÓŮҲ±£´æ×ÅѪÓѲ¡µÄ»¼²¡Î£º¦¡£Òò´Ë£¬¼´¼´ÊÇ¿µ½¡Õý³£µÄØøÙ³£¬ÔÚ±¸ÔÐÆÚ»òÕßÔÐÔçÆÚ¾ÙÐÐѪÓѲ¡Ïà¹ØµÄ»ùÒòɸ²éÒ²ÊǺÜÊÇÓÐÒâÒåµÄ£¬Õâ¿ÉÒÔ×ÊÖúËûÃÇÏàʶ×ÔÉíµÄÖ²¡»ùÒòЯ´øÇéÐΣ¬ÖªÏþ×ÓÅ®µÄ»¼²¡Î£º¦²¢¾ÙÐпÆѧµÄÉúÓý¹ÜÀí£¬´Ó¶øµÖ´ïÓÅÉúÓÅÓýµÄÄ¿µÄ£¬ÓÐÓýµµÍѪÓѲ¡µÄ·¢²¡ÂÊ¡£
²Î¿¼ÎÄÏ×
[1] ÖлªÒ½Ñ§»áѪҺѧ·Ö»áѪ˨ÓëֹѪѧ×é, & ÖйúѪÓѲ¡Ð×÷×é. (2017). ѪÓѲ¡Õï¶ÏÓëÖÎÁÆÖйúר¼Ò¹²Ê¶(2017Äê°æ). ÖлªÑªÒºÑ§ÔÓÖ¾, 38(5), 364-370.
[2] ÖлªÒ½Ñ§»áѪҺѧ·Ö»áѪ˨ÓëֹѪѧ×é, & ÖйúѪÓѲ¡Ð×÷×é. (2020). ѪÓѲ¡ÖÎÁÆÖйúÖ¸ÄÏ(2020Äê°æ).
[3] Ljung, Rolf,Auerswald, Guenter,Benson, Gary, et al. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients[J].European Journal of Haematology.2019,102(2).
[4] ʯºìËÉ, À¸Ö, ÒüÑÞ, ÍõÓ§, & Íõ´¿. (2016). ¼×ÐÍѪÓѲ¡»ùÒòЯ´øÕß¼ì³ö¼°²úÇ°Õï¶ÏÑо¿. ÖлªÊÊÓÃÕï¶ÏÓëÖÎÁÆÔÓÖ¾, 30(4), 3.